课题基金 / 基金详情

PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS

PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
复发性非霍奇金病患者口服依托泊苷的药效学模型
批准号：
6297218
负责人：
Thomas C. Shea
金额：
$0.02万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6297218
关键词：
age difference clinical research drug screening /evaluation etoposide human subject human therapy evaluation neoplasm /cancer chemotherapy nonHodgkin's lymphoma oral administration pharmacokinetics

项目摘要

项目成果

Thomas C. Shea的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PURPOSE OF STUDY: The objectives of this study are: (1) to monitor etoposide trough levels and determine the pharmacodynamic relationships benween etoposide concentration, tumor response, and toxicity, as well as the pharmacokinetic relationship between etoposide concentration and age; (2) to evaluate the response rate and response duration of previously treated non-Hodgkin's lymphoma IWF A-H to daily oral etoposide; (3) to assess the toxicity of oral etoposide in patients with relapsed NHL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM
FILGRASTIM ALONE OR IN COMBINATION W/ R METHUSCF IN BREAST CANCER
PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
海外基金